16,116 followers
This trial follows the preclinical characterization of nemtabrutinib/ ARQ 531 published in @CD_AACR (prior to ArQule’s acquisition) https://t.co/ZbUeKmHg97 https://t.co/fDUEzrIqdG
2,181 followers
RT @ElizSMcKenna: ICYMI last year in @CD_AACR, seems quite relevant to today’s events at #ASH19, looking forward to seeing the clinical res…
20,356 followers
RT @ElizSMcKenna: ICYMI last year in @CD_AACR, seems quite relevant to today’s events at #ASH19, looking forward to seeing the clinical res…
16,116 followers
ICYMI last year in @CD_AACR, seems quite relevant to today’s events at #ASH19, looking forward to seeing the clinical results! https://t.co/JkCWw37SnG